| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | ORMDL3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | CYC1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SH3BGRL3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CCNG2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CCDC28B | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | SLC22A18 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | LUC7L3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SYCN | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | NUMB | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
